A new clinical study suggests that narrow Band Ultraviolet B (NB-UVB) phototherapy is effective, well-tolerated treatment for ...
By Lori Solomon HealthDay ReporterTHURSDAY, Oct. 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
For vitiligo, combining phototherapy with topical antioxidants, corticosteroids, or calcineurin inhibitors may offer the best ...
Experts are calling for an outright ban of sunbeds, but some claim they have wellness benefits. We asked dermatologists if it ...
Pat Thomas from Beyond GM was quoted by BBC News as saying there should be "an abundance of precaution" when it comes to GM ...
Johnson & Johnson has announced that the US Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for use in ...
More than just belly rubs, canine massage can improve flexibility, ease joint pain and improve the quality of life for dogs.
Discover a study on psoriasis treatment failure, highlighting when to move from topical therapies to systemic care for ...
Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® ...
Live Science on MSN
Scientists are unraveling the link between pollution and psoriasis
Researchers are uncovering how air pollution can trigger and worsen psoriasis, a chronic skin disease affecting millions ...
ALMOST £166,000 will be drawn from a charitable trust to fund the purchase of new equipment for the Hospital. A recent ministerial decision will see £37,715 transferred from the E. J. Bailhache ...
The FDA has expanded the approval of Tremfya to include pediatric patients 6 years and older weighing at least 40kg for the treatment of moderate to severe plaque PsO and active PsA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback